Hospira Tomudex powder for solution for infusion 2 mg/vial

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

raltitrexed, Quantity: 2 mg

Available from:

Hospira Australia Pty Ltd

INN (International Name):

Raltitrexed

Pharmaceutical form:

Injection, powder for

Composition:

Excipient Ingredients: mannitol; dibasic sodium phosphate dodecahydrate

Administration route:

Intravenous Infusion

Units in package:

1 x 10 mL pack

Class:

Medicine Listed (Export Only)

Prescription type:

(S1) This Schedule is intentionally blank

Therapeutic indications:

Pallative treatment of advanced colorectal cancer where 5-Flourouracil and folinic acid based regimens are either not tolerated or inappropriate.

Product summary:

Visual Identification: A white to cream coloured solid cake or plug practically free from visible impurities. The reconstituted solution is practically free from visible particulate matter; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure and restricted flow insert

Authorization status:

Licence status A

Authorization date:

2012-02-20